百傲化学(603360) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was CNY 338,254,118.94, representing a year-on-year increase of 31.18%[3] - The net profit attributable to shareholders for the same period was CNY 98,313,016.16, up 35.31% compared to the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 93,921,207.19, reflecting a 30.80% increase year-on-year[3] - The basic and diluted earnings per share were both CNY 0.27, an increase of 28.57% from the same period last year[3] - The weighted average return on equity rose to 5.83%, an increase of 0.98 percentage points[3] - The total comprehensive income for Q1 2024 was CNY 96,119,230.93, compared to CNY 71,180,490.46 in Q1 2023, reflecting a growth of 35.1%[18] - In Q1 2024, the company reported a net profit of CNY 98,313,016.16, an increase of 35.4% compared to CNY 72,655,074.26 in Q1 2023[17] - The company's operating profit for Q1 2024 was CNY 112,460,817.84, up from CNY 83,489,511.25 in the same period last year, representing a growth of 34.6%[17] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,092,038,427.31, a 7.74% increase from the end of the previous year[3] - Total current assets as of March 31, 2024, amounted to RMB 1,433,794,732.85, compared to RMB 1,267,435,233.60 at the end of Q1 2023, indicating a growth of 13.1%[12] - The company's total assets increased to RMB 2,092,038,427.31 in Q1 2024 from RMB 1,941,704,269.90 in Q1 2023, representing a growth of 7.8%[13] - Total liabilities as of March 31, 2024, were RMB 352,981,265.92, compared to RMB 304,985,193.24 in Q1 2023, marking an increase of 15.7%[14] - The company's equity attributable to shareholders reached RMB 1,739,057,161.39 in Q1 2024, up from RMB 1,636,719,076.66 in Q1 2023, reflecting a growth of 6.3%[14] Cash Flow and Financing - The company reported a net cash flow from operating activities of -CNY 53,716,985.51, which is not applicable for year-on-year comparison[3] - The company generated operating cash flow of CNY -53,716,985.51 in Q1 2024, a decrease from CNY 113,334,039.98 in Q1 2023[20] - Cash and cash equivalents stood at RMB 519,246,919.05 as of March 31, 2024, slightly down from RMB 539,523,884.78 in the previous quarter[12] - Cash and cash equivalents at the end of Q1 2024 amounted to CNY 503,246,919.03, up from CNY 494,259,888.39 at the end of Q1 2023[20] - The company raised CNY 150,000,000.00 in borrowings during Q1 2024, compared to CNY 50,000,000.00 in Q1 2023, indicating a significant increase in financing activities[20] Operating Costs and Expenses - Operating costs for Q1 2024 were RMB 182,957,863.16, up from RMB 125,734,078.59 in Q1 2023, reflecting a year-over-year increase of 45.5%[16] - The total operating expenses for Q1 2024 were CNY 42,501,000.00, compared to CNY 36,626,000.00 in Q1 2023, reflecting an increase of 16.1%[19] - Research and development expenses increased to CNY 10,344,933.50 in Q1 2024, compared to CNY 7,867,543.25 in Q1 2023, marking a rise of 31.4%[17] Shareholder Information - The company had a total of 12,831 common shareholders at the end of the reporting period[8] - The total equity attributable to shareholders was CNY 1,739,057,161.39, up 6.25% from the previous year[4] Other Financial Metrics - Government subsidies recognized in the current period amounted to CNY 3,024,556.11, contributing to the overall financial performance[5] - Accounts receivable increased to RMB 215,834,350.45 in Q1 2024 from RMB 140,136,870.10 in Q1 2023, showing a rise of 54.0%[12] - Inventory decreased to RMB 147,894,083.60 in Q1 2024 from RMB 206,935,171.71 in Q1 2023, a decline of 28.5%[12] - The company reported a foreign exchange gain of CNY 223.55 in Q1 2024, compared to a loss of CNY 2,636.75 in Q1 2023, indicating a positive shift in currency impact[18]